Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

TRV53

TRV53 focuses on bringing precision treatments to patients with immune-mediated diseases by developing novel medicines that tune immune cell function and fate.

TRV53 logo
Website - Coming Soon
  • Bhavana Priyadharshini Scientist